Catalyst Pharmaceuticals Statistics
Total Valuation
CPRX has a market cap or net worth of $2.00 billion. The enterprise value is $1.69 billion.
| Market Cap | 2.00B |
| Enterprise Value | 1.69B |
Important Dates
The next estimated earnings date is Wednesday, August 7, 2024, after market close.
| Earnings Date | Aug 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CPRX has 118.12 million shares outstanding. The number of shares has increased by 8.26% in one year.
| Shares Outstanding | 118.12M |
| Shares Change (YoY) | +8.26% |
| Shares Change (QoQ) | +8.48% |
| Owned by Insiders (%) | 6.21% |
| Owned by Institutions (%) | 83.33% |
| Float | 101.66M |
Valuation Ratios
The trailing PE ratio is 31.37 and the forward PE ratio is 14.86.
| PE Ratio | 31.37 |
| Forward PE | 14.86 |
| PS Ratio | 4.86 |
| Forward PS | 4.00 |
| PB Ratio | 3.56 |
| P/FCF Ratio | 12.27 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.85, with an EV/FCF ratio of 10.38.
| EV / Earnings | 26.01 |
| EV / Sales | 4.12 |
| EV / EBITDA | 13.85 |
| EV / EBIT | 19.63 |
| EV / FCF | 10.38 |
Financial Position
The company has a current ratio of 5.09, with a Debt / Equity ratio of 0.01.
| Current Ratio | 5.09 |
| Quick Ratio | 4.66 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.03 |
| Debt / FCF | 0.02 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 15.60% and return on invested capital (ROIC) is 10.47%.
| Return on Equity (ROE) | 15.60% |
| Return on Assets (ROA) | 13.20% |
| Return on Capital (ROIC) | 10.47% |
| Revenue Per Employee | $2.46M |
| Profits Per Employee | $389,922 |
| Employee Count | 167 |
| Asset Turnover | 0.83 |
| Inventory Turnover | 3.60 |
Taxes
In the past 12 months, CPRX has paid $21.17 million in taxes.
| Income Tax | 21.17M |
| Effective Tax Rate | 24.53% |
Stock Price Statistics
The stock price has increased by +24.83% in the last 52 weeks. The beta is 0.70, so CPRX's price volatility has been lower than the market average.
| Beta (5Y) | 0.70 |
| 52-Week Price Change | +24.83% |
| 50-Day Moving Average | 15.89 |
| 200-Day Moving Average | 14.88 |
| Relative Strength Index (RSI) | 65.11 |
| Average Volume (20 Days) | 1,260,766 |
Short Selling Information
The latest short interest is 5.30 million, so 4.49% of the outstanding shares have been sold short.
| Short Interest | 5.30M |
| Short Previous Month | 6.81M |
| Short % of Shares Out | 4.49% |
| Short % of Float | 5.22% |
| Short Ratio (days to cover) | 4.02 |
Income Statement
In the last 12 months, CPRX had revenue of $411.35 million and earned $65.12 million in profits. Earnings per share was $0.54.
| Revenue | 411.35M |
| Gross Profit | 356.81M |
| Operating Income | 78.33M |
| Pretax Income | 86.29M |
| Net Income | 65.12M |
| EBITDA | 122.26M |
| EBIT | 86.29M |
| Earnings Per Share (EPS) | $0.54 |
Balance Sheet
The company has $310.41 million in cash and $3.09 million in debt, giving a net cash position of $307.32 million or $2.60 per share.
| Cash & Cash Equivalents | 310.41M |
| Total Debt | 3.09M |
| Net Cash | 307.32M |
| Net Cash Per Share | $2.60 |
| Equity (Book Value) | 561.41M |
| Book Value Per Share | 4.75 |
| Working Capital | 325.04M |
Cash Flow
In the last 12 months, operating cash flow was $163.46 million and capital expenditures -$356,000, giving a free cash flow of $163.10 million.
| Operating Cash Flow | 163.46M |
| Capital Expenditures | -356,000 |
| Free Cash Flow | 163.10M |
| FCF Per Share | $1.40 |
Margins
Gross margin is 86.74%, with operating and profit margins of 19.04% and 15.83%.
| Gross Margin | 86.74% |
| Operating Margin | 19.04% |
| Pretax Margin | 20.98% |
| Profit Margin | 15.83% |
| EBITDA Margin | 29.72% |
| EBIT Margin | 20.98% |
| FCF Margin | 39.65% |
Dividends & Yields
CPRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.26% |
| Shareholder Yield | -8.26% |
| Earnings Yield | 3.25% |
| FCF Yield | 8.15% |
Analyst Forecast
The average price target for CPRX is $27.80, which is 64.11% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $27.80 |
| Price Target Difference | 64.11% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 11.59% |
| EPS Growth Forecast (5Y) | 34.02% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CPRX has an Altman Z-Score of 16.07 and a Piotroski F-Score of 8.
| Altman Z-Score | 16.07 |
| Piotroski F-Score | 8 |